共 50 条
- [31] Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trialJOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 52 (01) : 35 - 44Yuan, JinyiMo, BiwenMa, ZhuangLv, YuanCheng, Shih-LungYang, YanpingTong, ZhaohuiWu, RenguangSun, ShenghuaCao, ZhaolongWu, JufangZhu, DemeiChang, LiwenZhang, YingyuanZhao, LiWang, XiongbiaoWang, XuefenWang, DexiLi, XiangyangPeng, YiqiangLiang, YongjieLiu, HuaXiao, ZukeLv, XiaojuWu, ShimanDai, YuanrongHuang, YijiangHu, ZhenghongQiu, ChenLi, XiZhang, SuiyangLi, WenpuLiu, ShuangShi, YiXiong, ChangKuang, JiulongXiu, QingyuCui, ShehuaiLi, JianguoLin, QichangHuang, WenxiangWan, YixinLi, QimanguShen, CeXiao, YiWu, XiaojuChuang, Yin ChingPerng, Wann CherngTsao, Shih-MingHsu, Jeng-Yuan
- [32] Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase lll, non-inferiority, randomized clinical trial中华医学杂志英文版, 2024, 137 (12)Chen XueHan XiupingCheng BoLi HuiLiu LinglingGeng SongmeiLi LinfengLi JieGuo QingZhang GuoyiFang HongZhang Jianzhong
- [33] Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trialCHINESE MEDICAL JOURNAL, 2024, 137 (12) : 1480 - 1482Chen, XueHan, XiupingCheng, BoLi, HuiLiu, LinglingGeng, SongmeiLi, LinfengLi, JieGuo, QingZhang, GuoyiFang, HongZhang, Jianzhong
- [34] Safety and Efficacy of WC2031 Versus Vibramycin for the Treatment of Uncomplicated Urogenital Chlamydia trachomatis Infection: A Randomized, Double-blind, Double-Dummy, Active-Controlled, Multicenter TrialCLINICAL INFECTIOUS DISEASES, 2012, 55 (01) : 82 - 88Geisler, William M.Koltun, William D.Abdelsayed, NaderBurigo, JohnMena, LeandroTaylor, Stephanie N.Batteiger, Byron E.Thurman, Andrea R.Hook, Edward W., IIIVaughn, Toby A.Annett, Miriam P.Muenzen, Ruth A.Caminis, John
- [35] Optimal Dosing of Mesalamine for Maintenance of Clinical Remission in Patients With Distal Ulcerative Colitis and Residual Endoscopic Activity: A Subgroup Analysis of a Double-Blind, Double-Dummy, Randomized, Controlled, Dose-Ranging StudyGASTROENTEROLOGY, 2013, 144 (05) : S768 - S768Kruis, WolfgangGreinwald, RolandMueller, Ralph
- [36] Efficacy and Safety of Once-Daily Dosing of Udenafil in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialEUROPEAN UROLOGY, 2011, 60 (02) : 380 - 387Zhao, ChenKim, Sae WoongYang, Dae YulKim, Je JongPark, Nam CheolLee, Sung WonPaick, Jae SeungAhn, Tai YoungMin, Kweon SikPark, KwangsungPark, Jong Kwan
- [37] A double-blind, double-dummy, randomized, controlled, multicenter trial on the efficacy and safety of azathioprine vs mesalamine for prevention of clinical relapses in Crohn's disease patients with postoperative moderate or severe endoscopic recurrenceGASTROENTEROLOGY, 2008, 134 (04) : A70 - A70Reinisch, WalterAngelberger, SieglindePetritsch, WolfgangHerrlinger, KlausShonova, OlgaLukas, MilanBar-Meir, SimonSchwab, MatthiasGreinwald, RolandMueller, RalphStange, Eduard
- [38] Efficacy of Guselkumab in Bionaive Psoriatic Arthritis Patients with Severe Disease Activity: Post-hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled StudyARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2999 - 3001Ritchlin, ChristopherLubrano, EnnioChimenti, Maria SoleLeibowitz, EvanSharaf, MohamedAdelakun, OyediranRampakakis, EmmanouilNantel, FrancoisLavie, FredericDeodhar, Atul
- [39] Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trialJOURNAL OF CLINICAL VIROLOGY, 2004, 29 (04) : 248 - 253Shafran, SDTyring, SKAshton, RDecroix, JForszpaniak, CWade, APaulet, CCandaele, D
- [40] The effect of previous dose of oral aripiprazole (10 or 30 mg/day) on the efficacy and tolerability of aripiprazole once-monthly: Post-hoc analysis of two double-blind, randomized, controlled trialsINTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 149 - 150Nylander, A. -G.Eramo, A.Baker, R.Tsai, L. -F.Peters-Strickland, T.Sanchez, R.